Ctt Pharmaceutical Holdings annual shareholders’ equity
2007
2008
2009
2010
2011
2012
2013
2014
2024
2025
Ctt Pharmaceutical Holdings Shareholders’ Equity Growth & History (CTTH)
Ctt Pharmaceutical Holdings's shareholders’ equity was $55,150 for fiscal 2025.
View full Ctt Pharmaceutical Holdings company overviewCtt Pharmaceutical Holdings annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $55,150 | $22,967 | +71.36% |
| 2024 | 2024-12-31 | $32,183 | — | — |
| 2014 | 2014-12-31 | $1.5M | $1.5M | — |
| 2013 | 2013-12-31 | −$29,322 | −$9,322 | — |
| 2012 | 2012-12-31 | −$20,000 | −$476,450 | — |
| 2011 | 2011-12-31 | $456,450 | $774,339 | — |
| 2010 | 2010-12-31 | −$317,889 | $930,783 | — |
| 2009 | 2009-12-31 | −$1.2M | −$1.4M | — |
| 2008 | 2008-12-31 | $151,388 | −$406,474 | −72.86% |
| 2007 | 2007-12-31 | $557,862 | — | — |
Ctt Pharmaceutical Holdings quarterly shareholders’ equity
Q4.10
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $26,043 | −$56,096 | −68.29% |
| Q1 2026 | 2026-03-31 | $41,277 | — | — |
| Q4 2025 | 2025-12-31 | $55,150 | $22,967 | +71.36% |
| Q3 2025 | 2025-09-30 | $81,760 | — | — |
| Q2 2025 | 2025-06-30 | $82,139 | — | — |
| Q4 2024 | 2024-12-31 | $32,183 | — | — |
| Q3 2015 | 2015-09-30 | $738,078 | $731,930 | +11905.17% |
| Q2 2015 | 2015-06-30 | $1.0M | $941,331 | +1100.25% |
| Q1 2015 | 2015-03-31 | $1.2M | $1.5M | — |
| Q4 2014 | 2014-12-31 | $1.5M | $1.5M | — |
| Q3 2014 | 2014-09-30 | $6,148 | $496,280 | — |
| Q2 2014 | 2014-06-30 | $85,556 | $561,662 | — |
| Q1 2014 | 2014-03-31 | −$262,649 | $161,306 | — |
| Q4 2013 | 2013-12-31 | −$29,322 | −$9,322 | — |
| Q3 2013 | 2013-09-30 | −$490,132 | −$259,398 | — |
| Q2 2013 | 2013-06-30 | −$476,106 | −$533,066 | — |
| Q1 2013 | 2013-03-31 | −$423,955 | −$1.2M | — |
| Q4 2012 | 2012-12-31 | −$20,000 | −$476,450 | — |
| Q3 2012 | 2012-09-30 | −$230,734 | −$4.3M | — |
| Q2 2012 | 2012-06-30 | $56,960 | −$4.4M | −98.72% |
| Q1 2012 | 2012-03-31 | $767,763 | — | — |
| Q4 2011 | 2011-12-31 | $456,450 | $774,339 | — |
| Q3 2011 | 2011-09-30 | $4.1M | — | — |
| Q2 2011 | 2011-06-30 | $4.4M | — | — |
| Q4 2010 | 2010-12-31 | −$317,889 | — | — |
Ctt Pharmaceutical Holdings shareholders’ equity trends
Between the periods ended 2007-12-31 and 2025-12-31, Ctt Pharmaceutical Holdings's shareholders’ equity decreased from $557,862 to $55,150, a change of −$502,712. The latest reported quarter, Q2 2026, shows $26,043.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ctt Pharmaceutical Holdings source filings ↗